Drug Information for ONDANSETRON Oral Solution, USP (Roxane Laboratories, Inc): REFERENCE

Ads
    • Britto MR, Hussey EK, Mydlow P, et al. Effect of enzyme inducers on ondansetron (OND) metabolism in humans. Clin Pharmacol Ther. 1997;61:228.
    • Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Brit J Surg. 1973;60:646-649.
    • Villikka K, Kivisto KT, Neuvonen PJ. The effect of rifampin on the pharmacokinetics of oral and intravenous ondansetron. Clin Pharmacol Ther. 1999;65:377-381.
    • De Witte JL, Schoenmaekers B, Sessler DI, et al. Anesth Analg. 2001;92:1319-1321.
    • Arcioni R, della Rocca M, Romanò R, et al. Anesth Analg. 2002;94:1553-1557.

    10003003/02

    Revised December 2006

    © RLI, 2006

  • Drug Information Provided by National Library of Medicine (NLM).
Ads